2.43%XLF 15.10 
10.30%QQQQ 31.32 0.63%
The Global Business News Leader | Saturday, 11 Oct 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
OSI PHARMACEUTIC
OSIP (NASDAQ)
$ 37.55 
Change: -2.26 -6.02% | Volume: 2,228,594
Change: -2.26 -6.02% | Volume: 2,228,594
Sponsored by 
OSI PHARMA INC - Fundamental Profile
Company Information
| Ticker Symbol: | OSIP |
|---|---|
| Exchange: | NASD |
| Contact Info: | 41 Pinelawn Road Melville NY 11747 631 962-2000 |
| CEO/President: | Colin Goddard Ph.D. |
| Industry: | Medical - Biomedical / Standard Industry Code: 2835 |
| Description: | Osi Pharmaceuticals is one of the leading pharmaceutical research and development organizations, commercializing its skills in drug discovery, preclinical research, and drug development. The company has assembled an effective drug discovery and development capability comprised of a talented team of research scientists and business professionals. |
Share Information
| Shares Outstanding: | 57,200 (000) | Market Value: | 2,290,590 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 84.20% | Number of Inst.Shareholders: | 4.00% |
| Last Quarter Sales: | 95.65 ($Mil.) | Last Quarter Net Income: | 25.30 ($Mil.) |
| Last Quarter EPS: | 0.61 | P/E Ratio: | 19 |
| Most Recent Earnings: | 0.61 on 07/23/08 | Earnings Per Share: | 1.59 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
OSIP
Companies
IBT
- AIG Units Party, Luxury Resort Conference Upsets Watchdogs
- Ahead of the Bell: Morgan Stanley plunges
- Gold bullion and stocks shine during one of most volatile days
- Harley revs up cooler image with supermodel Miller
- Morgan Stanley shares sink on worries about future
- SEC head asks for reins on credit default swaps
- Harmony leads global gold pack
- W Magazine Angelina Jolie: I bought Maddox his first knife
- Brad Pitts exclusive photos of Angelina Jolie breastfeeding appears on W Magazine Cover
- Sarah Palin is Princess Dianas and Roosevelts distant cousin
- Angelina Jolie: My Twins Are Totally Sweet
- Ahead of Troopergate Report, NYT Says Official Pressured Indirectly
- Playboy Hugh Hefner New Girlfriends: Karissa and Kristina Shannon, Amy Leigh Andrews
- Hugh Heffner: Done With Holly Madison, Moves onto Karissa and Kristina Shannon
Top Competitors
| AMGEN |  |
+14.00 | 58.89 |
| GILEAD SCIENCES |  |
-0.20 | 45.75 |
| GENENTECH INC | |
+16.10 | 87.53 |
| CELGENE CP | |
-14.40 | 60.46 |
| BIOGEN IDEC INC | |
-16.30 | 50.50 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives